Yes, our product is designed to help with insulin resistance. The primary mechanism of action in our product is through the production of Glucagon-like peptide 1 (GLP-1).
GLP-1 plays a crucial role in improving insulin resistance, particularly in adipose tissue in obese individuals. While the precise mechanisms of this effect are still being studied, research has indicated that GLP-1 can enhance the insulin sensitivity of adipose tissue.
One of the proposed pathways through which GLP-1 helps alleviate insulin resistance is by perturbing endoplasmic reticulum (ER) homeostasis. Disruptions in ER homeostasis can impair insulin signaling, which is a key factor contributing to insulin resistance.
Our product is formulated with the intention of harnessing the potential benefits of GLP-1 to improve insulin resistance, especially in individuals facing challenges related to obesity and associated conditions.
If you are considering our product as part of your health and wellness plan to address insulin resistance, we recommend discussing it with a healthcare professional. They can provide you with personalized guidance and advice on how to incorporate our product into your routine to best meet your specific needs.
If you have any additional questions or concerns, please feel free to reach out to our customer support team at hello@bioma.health. We are here to assist you and provide the information you need to make informed decisions about your health.